In one experimental study, a suppression of the TGF-β/Smad3 pathway in WAT was shown to reduce obesity and regulate energy homeostasis/glucose tolerance in vitro. This evidence concerns the gene SMAD3 and obesity due to melanocortin 4 receptor deficiency.